Biologics

Orthopedic biologic company TheraCell was acquired by Isto Biologics, according to an April 5 news release.

Two-year data from a pilot study found the StemSpine regenerative procedure was effective for treating chronic lower back pain.

Zimmer Biomet has cemented a multiyear partnership with Biocomposites to exclusively distribute its Genex bone graft substitute in the U.S.

Becker's reported on five spine and orthopedic practices that have added regenerative medicine options in the last 90 days:

Ortho Regenerative Technologies named Philippe Deschamps as president and CEO.

The Center for Orthopedic Care in Fulton, N.Y., began offering a regenerative orthopedic treatment.

Surgeons at Yale Medicine in New Haven, Conn., are using stem cell treatments to treat some hip conditions without joint replacements, ABC affiliate WTNH reported March 1.

Campbell Medical Clinic in Houston added the stromal vascular fraction procedure, according to a Feb. 28 news release.

From product launches to research initiatives, here are six key updates since Jan. 1 to know in the regenerative medicine industry:

A Rhode Island man designed a first-of-its-kind spinal implant made from human bone tissue, NBC affiliate WJAR reported Feb. 23.